List of Excipients in API butalbital and acetaminophen
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing butalbital and acetaminophen
Detailed excipient profiles for butalbital and acetaminophen
Excipient focus: AMMONIA
butalbital and acetaminophen drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing AMMONIA
Excipient focus: CELLULOSE, MICROCRYSTALLINE
butalbital and acetaminophen drug variants containing CELLULOSE, MICROCRYSTALLINE
butalbital and acetaminophen drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
butalbital and acetaminophen drug variants containing CROSCARMELLOSE SODIUM
butalbital and acetaminophen drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
butalbital and acetaminophen drug variants containing CROSPOVIDONE
butalbital and acetaminophen drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Keltman Pharmaceuticals Inc | butalbital and acetaminophen and caffeine | 68387-520 |
| Bausch Health US LLC | butalbital and acetaminophen tablets | 0095-3000 |
| Oceanside Pharmaceuticals | butalbital and acetaminophen tablets | 68682-306 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
butalbital and acetaminophen drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| QUAGEN PHARMACEUTICALS LLC | butalbital and acetaminophen | 70752-147 |
| Bausch Health US LLC | butalbital and acetaminophen tablets | 0095-3000 |
| Oceanside Pharmaceuticals | butalbital and acetaminophen tablets | 68682-306 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
butalbital and acetaminophen drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | butalbital and acetaminophen | 42549-495 |
| Mayne Pharma | butalbital and acetaminophen | 51862-544 |
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 3
butalbital and acetaminophen drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | butalbital and acetaminophen | 51862-544 |
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
butalbital and acetaminophen drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| QUAGEN PHARMACEUTICALS LLC | butalbital and acetaminophen | 70752-147 |
| Bausch Health US LLC | butalbital and acetaminophen tablets | 0095-3000 |
| Oceanside Pharmaceuticals | butalbital and acetaminophen tablets | 68682-306 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing FD&C RED NO. 40
Excipient focus: FERROSOFERRIC OXIDE
butalbital and acetaminophen drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
butalbital and acetaminophen drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | butalbital and acetaminophen | 51862-544 |
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing GELATIN
Excipient focus: MAGNESIUM STEARATE
butalbital and acetaminophen drug variants containing MAGNESIUM STEARATE
butalbital and acetaminophen drug variants not containing MAGNESIUM STEARATE
Excipient focus: POVIDONE
butalbital and acetaminophen drug variants containing POVIDONE
butalbital and acetaminophen drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | butalbital and acetaminophen tablets | 0095-3000 |
| Oceanside Pharmaceuticals | butalbital and acetaminophen tablets | 68682-306 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
butalbital and acetaminophen drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
butalbital and acetaminophen drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
butalbital and acetaminophen drug variants containing SILICON DIOXIDE
butalbital and acetaminophen drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
butalbital and acetaminophen drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
butalbital and acetaminophen drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Keltman Pharmaceuticals Inc | butalbital and acetaminophen and caffeine | 68387-520 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
butalbital and acetaminophen drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mikart LLC | butalbital and acetaminophen | 46672-856 |
| Mayne Pharma | butalbital and acetaminophen | 51862-538 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
butalbital and acetaminophen drug variants containing STARCH, CORN
butalbital and acetaminophen drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Larken Laboratories Inc | butalbital and acetaminophen | 68047-721 |
| Atland Pharmaceuticals LLC | butalbital and acetaminophen | 71993-301 |
| Lacer Pharma LLC | butalbital and acetaminophen | 73159-003 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
butalbital and acetaminophen drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Larken Laboratories Inc | butalbital and acetaminophen | 68047-721 |
| Atland Pharmaceuticals LLC | butalbital and acetaminophen | 71993-301 |
| Lacer Pharma LLC | butalbital and acetaminophen | 73159-003 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: STEARIC ACID
butalbital and acetaminophen drug variants containing STEARIC ACID
butalbital and acetaminophen drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | butalbital and acetaminophen tablets | 0095-3000 |
| Oceanside Pharmaceuticals | butalbital and acetaminophen tablets | 68682-306 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
butalbital and acetaminophen drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
butalbital and acetaminophen drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | butalbital and acetaminophen | 51862-544 |
| Granules Pharmaceuticals Inc | butalbital and acetaminophen | 70010-054 |
| >Company | >Ingredient | >NDC |
butalbital and acetaminophen drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
